These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3495503)
1. The pharmacokinetics and toxicity of murine monoclonal antibodies and of gelonin conjugates of these antibodies. Scott CF; Lambert JM; Goldmacher VS; Blatter WA; Sobel R; Schlossman SF; Benacerraf B Int J Immunopharmacol; 1987; 9(2):211-25. PubMed ID: 3495503 [TBL] [Abstract][Full Text] [Related]
2. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors. Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356 [TBL] [Abstract][Full Text] [Related]
3. Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates. Sivam G; Pearson JW; Bohn W; Oldham RK; Sadoff JC; Morgan AC Cancer Res; 1987 Jun; 47(12):3169-73. PubMed ID: 3495329 [TBL] [Abstract][Full Text] [Related]
4. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin. Rosenblum MG; Marks JW; Cheung LH Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583 [TBL] [Abstract][Full Text] [Related]
5. The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin. Scott CF; Goldmacher VS; Lambert JM; Chari RV; Bolender S; Gauthier MN; Blättler WA Cancer Immunol Immunother; 1987; 25(1):31-40. PubMed ID: 3496157 [TBL] [Abstract][Full Text] [Related]
6. Immunotoxins composed of monoclonal antibody to alpha-fetoprotein and gelonin as a potent hepatoma-targeted drug delivery system. Masuda K; Takahashi K; Nagata S; Hirano K; Takagishi Y J Drug Target; 1994; 2(4):323-31. PubMed ID: 7532086 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin. Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201 [TBL] [Abstract][Full Text] [Related]
8. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin. Reimann KA; Goldmacher VS; Lambert JM; Chalifoux LV; Cook SB; Schlossman SF; Letvin NL J Clin Invest; 1988 Jul; 82(1):129-38. PubMed ID: 2899092 [TBL] [Abstract][Full Text] [Related]
9. Selective antitumor effect of thioether-linked immunotoxins composed of gelonin and monoclonal antibody to alpha-fetoprotein or its F(ab')2 fragment. Masuda K; Takahashi K; Hirano K; Takagishi Y Tumour Biol; 1994; 15(3):175-83. PubMed ID: 7521059 [TBL] [Abstract][Full Text] [Related]
10. Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies. French RR; Penney CA; Browning AC; Stirpe F; George AJ; Glennie MJ Br J Cancer; 1995 May; 71(5):986-94. PubMed ID: 7734325 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin. Mujoo K; Cheung L; Murray JL; Rosenblum MG Cancer Immunol Immunother; 1995 May; 40(5):339-45. PubMed ID: 7600567 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the increased cytotoxicity of gelonin anti-T cell immunoconjugates compared with ricin A chain immunoconjugates. Fishwild DM; Wu HM; Carroll SF; Bernhard SL Clin Exp Immunol; 1994 Jul; 97(1):10-8. PubMed ID: 8033405 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of antiproliferative effects of monoclonal antibody Lym-1 and immunoconjugate Lym-1-gelonin on human Burkitt's lymphoma cells with gamma-interferon and tumor necrosis factor. O'Boyle KP; Colletti D; Mazurek C; Wang Y; Ray SK; Diamond B; Rosenblum MG; Epstein AL; Shochat D; Dutcher JP J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):221-30. PubMed ID: 8680650 [TBL] [Abstract][Full Text] [Related]
14. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma. Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030 [TBL] [Abstract][Full Text] [Related]
15. A gelonin-containing immunotoxin directed against human breast carcinoma. Rosenblum MG; Zuckerman JE; Marks JW; Rotbein J; Allen WR Mol Biother; 1992 Sep; 4(3):122-9. PubMed ID: 1445665 [TBL] [Abstract][Full Text] [Related]
16. Toxicity of, and histological lesions caused by, ribosome-inactivating proteins, their IgG-conjugates, and their homopolymers. Battelli MG; Barbieri L; Stirpe F APMIS; 1990 Jul; 98(7):585-93. PubMed ID: 2397111 [TBL] [Abstract][Full Text] [Related]
17. Targeting of type 1 ribosome-inactivating proteins to CD30+ or CD25+ hematologic neoplasias by bispecific antibodies. Sforzini S; Bolognesi A; Meazza R; Marciano S; Tazzari PL; Stein H; Stirpe F; Ferrini S J Hematother; 1995 Oct; 4(5):429-32. PubMed ID: 8581380 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of cellular trafficking and cytotoxicity of 9.2.27-gelonin immunotoxins targeted against the high-molecular-weight melanoma-associated antigen. Chan MC; Murphy RM Cancer Immunol Immunother; 1999 Feb; 47(6):321-9. PubMed ID: 10203062 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to gelonin: production and characterization. Zimmermann J; Trommer WE Hybridoma; 1991 Feb; 10(1):65-76. PubMed ID: 2032735 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis. Goldmacher VS; Scott CF; Lambert JM; McIntyre GD; Blättler WA; Collnhson AR; Stewart JK; Chong LD; Cook S; Slayter HS J Cell Physiol; 1989 Oct; 141(1):222-34. PubMed ID: 2528553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]